The Traderszone Network

Published in TZ Latest News 8 November, 2014 by The TZ Newswire Staff

Solazyme Pivots Commercialization Strategy, But Does Amyris Do It Better?

Solazyme realized that it needs to sell high value products to survive, but Amyris realized that over 12 months ago. What can investors learn from execution at Amyris, and how does it translate to the new strategy at Solazyme?

read more